Abstract
Background: It is expected that incidence of anti-TNF alpha induced lupus (ATIL) will probably increase with more widespread use of anti-tumor necrosis factor-alpha (anti-TNF alpha) agents.
Case Report: We report a rare presentation of ATIL with hepatitis for a woman who has Crohn's disease and was treated with infliximab for 9 months. She had clinical and biochemical improvement after discontinuation of infliximab and starting steroid therapy.
Conclusion: Treatment with Infliximab may cause a lupus-like syndrome, which can be reversed upon its discontinuation.